Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16856 | 567 | 47.8 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PIN1 | Author keyword | 163 | 60% | 32% | 180 |
2 | ESS1 | Author keyword | 12 | 86% | 1% | 6 |
3 | WW DOMAIN | Author keyword | 8 | 23% | 5% | 31 |
4 | PIN 1 | Author keyword | 8 | 62% | 1% | 8 |
5 | PPIASE | Author keyword | 6 | 22% | 4% | 24 |
6 | PIN1 INHIBITOR | Author keyword | 6 | 100% | 1% | 4 |
7 | PARVULIN | Author keyword | 5 | 45% | 2% | 9 |
8 | PEPTIDYL PROLYL ISOMERASE | Author keyword | 5 | 24% | 3% | 18 |
9 | MEDCANC BIOL PROGRAM | Address | 5 | 50% | 1% | 7 |
10 | STRUCT MED BIOCHEM | Address | 5 | 50% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PIN1 | 163 | 60% | 32% | 180 | Search PIN1 | Search PIN1 |
2 | ESS1 | 12 | 86% | 1% | 6 | Search ESS1 | Search ESS1 |
3 | WW DOMAIN | 8 | 23% | 5% | 31 | Search WW+DOMAIN | Search WW+DOMAIN |
4 | PIN 1 | 8 | 62% | 1% | 8 | Search PIN+1 | Search PIN+1 |
5 | PPIASE | 6 | 22% | 4% | 24 | Search PPIASE | Search PPIASE |
6 | PIN1 INHIBITOR | 6 | 100% | 1% | 4 | Search PIN1+INHIBITOR | Search PIN1+INHIBITOR |
7 | PARVULIN | 5 | 45% | 2% | 9 | Search PARVULIN | Search PARVULIN |
8 | PEPTIDYL PROLYL ISOMERASE | 5 | 24% | 3% | 18 | Search PEPTIDYL+PROLYL+ISOMERASE | Search PEPTIDYL+PROLYL+ISOMERASE |
9 | PHOSPHORYLATION SIGNALING | 4 | 75% | 1% | 3 | Search PHOSPHORYLATION+SIGNALING | Search PHOSPHORYLATION+SIGNALING |
10 | PROLYL ISOMERASE | 2 | 22% | 2% | 10 | Search PROLYL+ISOMERASE | Search PROLYL+ISOMERASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROLYL ISOMERASE PIN1 | 111 | 45% | 32% | 183 |
2 | DEPENDENT PROLINE ISOMERIZATION | 99 | 87% | 8% | 48 |
3 | PIN1 | 25 | 42% | 8% | 46 |
4 | ESS1 | 19 | 80% | 2% | 12 |
5 | MITOTIC REGULATOR HPIN1 | 19 | 80% | 2% | 12 |
6 | HPAR14 | 17 | 100% | 1% | 8 |
7 | REGULATORY MECHANISM | 14 | 26% | 8% | 46 |
8 | 842G GREATER THAN C | 14 | 100% | 1% | 7 |
9 | PHOSPHOSERINE BINDING | 11 | 100% | 1% | 6 |
10 | PEPTIDYLPROLYL ISOMERASE | 8 | 100% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The prolyl isomerase PIN 1: a pivotal new twist in phosphorylation signalling and disease | 2007 | 245 | 133 | 60% |
Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins | 2011 | 94 | 138 | 52% |
Prolyl isomerase Pin1 in cancer | 2014 | 9 | 128 | 63% |
Prolyl cis-trans isomerization as a molecular timer | 2007 | 233 | 124 | 43% |
PIN1, the cell cycle and cancer | 2007 | 113 | 88 | 69% |
Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease | 2015 | 1 | 94 | 55% |
Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer | 2008 | 38 | 65 | 89% |
Versatile communication strategies among tandem WW domain repeats | 2015 | 2 | 54 | 28% |
Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease | 2011 | 47 | 172 | 49% |
Pinning down cell signaling, cancer and Alzheimer's disease | 2004 | 148 | 66 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MEDCANC BIOL PROGRAM | 5 | 50% | 1.2% | 7 |
2 | STRUCT MED BIOCHEM | 5 | 50% | 1.2% | 7 |
3 | MED HEMATOL ONCOLCANC BIOL PROGRAM | 4 | 38% | 1.6% | 9 |
4 | MEDCANC BIOL PROGRAM HEMATOL ONCOL | 3 | 60% | 0.5% | 3 |
5 | MOL CELL SCI | 2 | 17% | 2.1% | 12 |
6 | ELE ON MICROSCOPE S | 2 | 67% | 0.4% | 2 |
7 | UW CARBONE COMPREHENS CANC | 2 | 67% | 0.4% | 2 |
8 | WAISMAN DEV DISABILITIES | 1 | 100% | 0.4% | 2 |
9 | WAISMAN DEV DISABIL | 1 | 21% | 0.9% | 5 |
10 | CANC BIOL PROGRAM HEMATOL ONCOL MED | 1 | 40% | 0.4% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000162013 | CYCLOPHILIN//PEPTIDYL PROLYL CIS TRANS ISOMERASE//IMMUNOPHILIN |
2 | 0.0000153508 | WWP1//SMURF1//CKIP 1 |
3 | 0.0000107428 | FE65//ALCADEIN//X11 ALPHA |
4 | 0.0000079082 | P TEFB//CDK9//HEXIM1 |
5 | 0.0000075137 | GAS7//GAS1//GROWTH ARREST SPECIFIC 1 |
6 | 0.0000074461 | FBXW7//FBW7//HCDC4 |
7 | 0.0000072250 | NIMA//NEK6//NEK2 |
8 | 0.0000065857 | FLIGHTLESS I//TTYH1//TWEETY |
9 | 0.0000051414 | GRB2//SH2 DOMAIN//SH3 DOMAIN |
10 | 0.0000049569 | HIPPO PATHWAY//YAP//HIPPO |